Clinical trial

Clinical Pathway for Alzheimer's Disease in China (CPAD)

NCT01779310

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2012-11-01

PhaseN/A

Study timeline

Study start (unknown)2012-11-01Date precision: month

Registry last updated2017-07-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mild Cognitive Impairmentunresolved

Alzheimer's Diseaseunresolved

Dementiaunresolved

Interventions

Sponsors & collaborators

Peking Universitylead sponsor

Beijing Novartis Pharmacollaborator

Mapped research locations

BeijingBeijing Municipality, China7 ShanghaiShanghai Municipality, China3 GuangzhouGuangdong, China2 HangzhouZhejiang, China2 JinanShandong, China2 TianjinTianjin Municipality, China2 NanjingJiangsu, China1 ChengduSichuan, China1 HefeiAnhui, China1 NanchangJiangxi, China1 Xi'anShaanxi, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01779310 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.